JPS5965017A - 関節拘縮、強直治療剤 - Google Patents
関節拘縮、強直治療剤Info
- Publication number
- JPS5965017A JPS5965017A JP17689382A JP17689382A JPS5965017A JP S5965017 A JPS5965017 A JP S5965017A JP 17689382 A JP17689382 A JP 17689382A JP 17689382 A JP17689382 A JP 17689382A JP S5965017 A JPS5965017 A JP S5965017A
- Authority
- JP
- Japan
- Prior art keywords
- joint
- therapy
- remedy
- human placental
- joints
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000008037 Arthrogryposis Diseases 0.000 title abstract 3
- 239000006286 aqueous extract Substances 0.000 claims abstract 6
- 239000002674 ointment Substances 0.000 claims abstract 2
- 210000002826 placenta Anatomy 0.000 claims description 25
- 206010023198 Joint ankylosis Diseases 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 12
- 229940124597 therapeutic agent Drugs 0.000 claims description 11
- 208000008822 Ankylosis Diseases 0.000 claims description 10
- 206010023201 Joint contracture Diseases 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 28
- 239000000284 extract Substances 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 10
- 210000002808 connective tissue Anatomy 0.000 abstract description 7
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 230000035699 permeability Effects 0.000 abstract description 5
- 210000001519 tissue Anatomy 0.000 abstract description 4
- 230000006371 metabolic abnormality Effects 0.000 abstract description 3
- 230000003169 placental effect Effects 0.000 abstract 5
- 239000000470 constituent Substances 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000003883 ointment base Substances 0.000 abstract 1
- 208000006111 contracture Diseases 0.000 description 15
- 206010062575 Muscle contracture Diseases 0.000 description 11
- 210000001503 joint Anatomy 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 208000010392 Bone Fractures Diseases 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 210000000629 knee joint Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 206010017076 Fracture Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000000544 articulatio talocruralis Anatomy 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N n-octadecyl alcohol Natural products CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 238000000554 physical therapy Methods 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- -1 Polyoxyethylene cetyl ether phosphate Polymers 0.000 description 3
- 229920002675 Polyoxyl Polymers 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 210000002082 fibula Anatomy 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 210000004417 patella Anatomy 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- 239000003871 white petrolatum Substances 0.000 description 2
- 210000003857 wrist joint Anatomy 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- 206010053962 Epiphyseal fracture Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010023330 Keloid scar Diseases 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17689382A JPS5965017A (ja) | 1982-10-06 | 1982-10-06 | 関節拘縮、強直治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17689382A JPS5965017A (ja) | 1982-10-06 | 1982-10-06 | 関節拘縮、強直治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5965017A true JPS5965017A (ja) | 1984-04-13 |
| JPS6234723B2 JPS6234723B2 (en]) | 1987-07-28 |
Family
ID=16021589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17689382A Granted JPS5965017A (ja) | 1982-10-06 | 1982-10-06 | 関節拘縮、強直治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5965017A (en]) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63172028U (en]) * | 1987-04-30 | 1988-11-09 | ||
| DE8708373U1 (de) * | 1987-06-13 | 1987-08-13 | Preh, Elektrofeinmechanische Werke Jakob Preh Nachf. Gmbh & Co, 8740 Bad Neustadt | Drucktasteneinrichtung |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4830370A (en]) * | 1971-08-18 | 1973-04-21 | ||
| JPS565202A (en) * | 1979-06-19 | 1981-01-20 | Ladney M Jr | Wheel cover |
-
1982
- 1982-10-06 JP JP17689382A patent/JPS5965017A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4830370A (en]) * | 1971-08-18 | 1973-04-21 | ||
| JPS565202A (en) * | 1979-06-19 | 1981-01-20 | Ladney M Jr | Wheel cover |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6234723B2 (en]) | 1987-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104398603A (zh) | 颈椎腰椎腿关节中草药热敷治疗袋及其使用方法 | |
| FRIEDLANDER et al. | Tennis elbow | |
| US20020006904A1 (en) | Method of treating inflammation in the joints of a body | |
| CN102228586A (zh) | 一种促进骨伤骨折愈合的药膏及其制备方法 | |
| JPS5965017A (ja) | 関節拘縮、強直治療剤 | |
| JP4652689B2 (ja) | 骨再生を促進するカルモジュリンの使用 | |
| Baird et al. | External fixation of femoral shaft fractures in spinal cord injury patients | |
| CN115551495A (zh) | 管理损伤后面部挛缩的治疗策略 | |
| CN111529590A (zh) | 一种治疗骨折和/或软组织扭挫伤的药物组合物及其使用方法 | |
| RU2071336C1 (ru) | Лекарственное средство для наружного применения на основе ткани плаценты | |
| ZOLTAN | TREATMENT OF ANKLE SPRAINS WITH JOINT ASPIRATION, XYLOCAINE INFILTRATION, AND EARLY MOBILIZATION: ANKLE SPRAINS TREATED WITH XYLOCAINE INFILTRATION AND EARLY MOBILIZATION | |
| CN108904638A (zh) | 一种多用途的外用复合药物及应用 | |
| Welch et al. | Frostbite of the hands | |
| MONTEITH et al. | THE TREATMENT OF BURNS WITH NORMAL HORSE SERUM: REPORT OF CASES | |
| Shams Eldin Mohammed et al. | THE RULE OF PONSETI TECHNIQUE FOR CORRECTION OF RECURRENT CASES OF CONGENITAL TALIPES EQUINO VARUS | |
| KAPLAN | Multiple fractures associated with blue sclera | |
| RU2315597C1 (ru) | Средство, обладающее ангиотропным действием (варианты) | |
| CN104523817A (zh) | 一种用于治疗类风湿性关节炎的中药组合物 | |
| SU1090394A1 (ru) | Способ лечени больных ревматоидным артритом | |
| CN113456703A (zh) | 一种舒筋利节中药药膏及其制备方法 | |
| SU1174032A1 (ru) | Способ лечени псориатической артропатии | |
| CN1316987C (zh) | 治疗颈腰椎关节炎的膏药 | |
| CN117899055A (zh) | 一种适用于类风湿性关节炎的雷公藤甲素穴位敷贴 | |
| Nutter | Orthopaedics | |
| Benjamin et al. | The Link with Medical Management |